Literature DB >> 8344906

A Kazal-type inhibitor with thrombin specificity from Rhodnius prolixus.

T Friedrich1, B Kröger, S Bialojan, H G Lemaire, H W Höffken, P Reuschenbach, M Otte, J Dodt.   

Abstract

A thrombin-specific inhibitor with an apparent molecular mass of 11 kDa has been purified from the insect Rhodnius prolixus. Amino-terminal protein sequence analysis allowed the molecular cloning of the corresponding cDNA. The open reading frame codes for a protein of about 103 amino acid residues and displays an internal sequence homology of residues 6-48 with residues 57-101 indicating a two-domain structure. Based on the amino acid sequence the two domains exhibit high homology to protease inhibitors belonging to the Kazal-type family. Model building suggests that the first domain binds to the active site with residue His10 pointing into the specificity pocket. From gel filtration and tight-binding inhibition experiments the inhibitor appears to form 1:1 complexes with thrombin. Periplasma-directed heterologous expression of the rhodniin cDNA in Escherichia coli yields the intact thrombin inhibitor. Natural and recombinant rhodniin both display inhibition constants of about 2 x 10(-13) M.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344906

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  DipoCoup: A versatile program for 3D-structure homology comparison based on residual dipolar couplings and pseudocontact shifts.

Authors:  J Meiler; W Peti; C Griesinger
Journal:  J Biomol NMR       Date:  2000-08       Impact factor: 2.835

2.  A catalog for the transcripts from the venomous structures of the caterpillar Lonomia obliqua: identification of the proteins potentially involved in the coagulation disorder and hemorrhagic syndrome.

Authors:  Ana B G Veiga; José M C Ribeiro; Jorge A Guimarães; Ivo M B Francischetti
Journal:  Gene       Date:  2005-08-01       Impact factor: 3.688

Review 3.  Receptor-targeting mechanisms of pain-causing toxins: How ow?

Authors:  Christopher J Bohlen; David Julius
Journal:  Toxicon       Date:  2012-04-14       Impact factor: 3.033

4.  An insight into the sialome of the blood-sucking bug Triatoma infestans, a vector of Chagas' disease.

Authors:  Teresa C F Assumpção; Ivo M B Francischetti; John F Andersen; Alexandra Schwarz; Jaime M Santana; José M C Ribeiro
Journal:  Insect Biochem Mol Biol       Date:  2007-11-17       Impact factor: 4.714

5.  Site-specific interaction of thrombin and inhibitors observed by fluorescence correlation spectroscopy.

Authors:  J Klingler; T Friedrich
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

6.  Isolation and properties of two forms of thrombin inhibitor from the nymphs of the camel tick Hyalomma dromedarii (Acari: Ixodidae).

Authors:  M A Ibrahim; A H Ghazy; T Maharem; M Khalil
Journal:  Exp Appl Acarol       Date:  2001       Impact factor: 2.132

7.  Purification and characterization of prolixin S (nitrophorin 2), the salivary anticoagulant of the blood-sucking bug Rhodnius prolixus.

Authors:  J M Ribeiro; M Schneider; J A Guimarães
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Identity and transfer of male reproductive gland proteins of the dengue vector mosquito, Aedes aegypti: potential tools for control of female feeding and reproduction.

Authors:  Laura K Sirot; Rebecca L Poulson; M Caitlin McKenna; Hussein Girnary; Mariana F Wolfner; Laura C Harrington
Journal:  Insect Biochem Mol Biol       Date:  2007-10-25       Impact factor: 4.714

Review 9.  Thrombin inhibitors from different animals.

Authors:  A M Tanaka-Azevedo; K Morais-Zani; R J S Torquato; A S Tanaka
Journal:  J Biomed Biotechnol       Date:  2010-10-04

10.  Brasiliensin: A novel intestinal thrombin inhibitor from Triatoma brasiliensis (Hemiptera: Reduviidae) with an important role in blood intake.

Authors:  R N Araujo; I T N Campos; A S Tanaka; A Santos; N F Gontijo; M J Lehane; M H Pereira
Journal:  Int J Parasitol       Date:  2007-05-10       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.